AU1690697A - Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin antagonists - Google Patents

Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin antagonists

Info

Publication number
AU1690697A
AU1690697A AU16906/97A AU1690697A AU1690697A AU 1690697 A AU1690697 A AU 1690697A AU 16906/97 A AU16906/97 A AU 16906/97A AU 1690697 A AU1690697 A AU 1690697A AU 1690697 A AU1690697 A AU 1690697A
Authority
AU
Australia
Prior art keywords
interleukin
receptor
screening
expression system
baculovirus expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16906/97A
Inventor
Peng Wang
Ji Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU1690697A publication Critical patent/AU1690697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
AU16906/97A 1996-01-17 1997-01-15 Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin antagonists Abandoned AU1690697A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US588795 1984-03-12
US1014196P 1996-01-17 1996-01-17
US010141 1996-01-17
US58879596A 1996-01-19 1996-01-19
PCT/US1997/000011 WO1997026332A1 (en) 1996-01-17 1997-01-15 Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists

Publications (1)

Publication Number Publication Date
AU1690697A true AU1690697A (en) 1997-08-11

Family

ID=26680833

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16906/97A Abandoned AU1690697A (en) 1996-01-17 1997-01-15 Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin antagonists

Country Status (2)

Country Link
AU (1) AU1690697A (en)
WO (1) WO1997026332A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906676B2 (en) 2004-02-02 2014-12-09 Ambrx, Inc. Modified human four helical bundle polypeptides and their uses
WO2006069220A2 (en) 2004-12-22 2006-06-29 Ambrx, Inc. Modified human growth hormone
WO2005085866A1 (en) * 2004-02-27 2005-09-15 Novartis Ag Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors
AU2005265163B2 (en) 2004-06-18 2009-10-01 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
WO2006091231A2 (en) 2004-07-21 2006-08-31 Ambrx, Inc. Biosynthetic polypeptides utilizing non-naturally encoded amino acids
SG158149A1 (en) 2004-12-22 2010-01-29 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
CA2590429C (en) 2004-12-22 2014-10-07 Ambrx, Inc. Compositions of aminoacyl-trna synthetase and uses thereof
NZ555386A (en) 2004-12-22 2011-01-28 Ambrx Inc Formulations of human growth hormone comprising a non-naturally encoded amino acid
CN103290084A (en) 2004-12-22 2013-09-11 Ambrx公司 Method for expression and purification of recombinant human growth hormone
EP1893229B1 (en) 2005-06-03 2011-10-19 Ambrx, Inc. Improved human interferon molecules and their uses
WO2007021297A1 (en) 2005-08-18 2007-02-22 Ambrx, Inc. COMPOSITIONS OF tRNA AND USES THEREOF
WO2007059312A2 (en) 2005-11-16 2007-05-24 Ambrx, Inc. Methods and compositions comprising non-natural amino acids
JP5451390B2 (en) 2006-09-08 2014-03-26 アンブルックス，インコーポレイテッド Transcription of suppressor TRNA in vertebrate cells
CA2662753C (en) 2006-09-08 2016-02-23 Ambrx, Inc. Hybrid suppressor trna for vertebrate cells
EP2069396B1 (en) 2006-09-08 2015-10-21 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
US8012931B2 (en) 2007-03-30 2011-09-06 Ambrx, Inc. Modified FGF-21 polypeptides and their uses
AU2008247815B2 (en) 2007-05-02 2012-09-06 Ambrx, Inc. Modified interferon beta polypeptides and their uses
MX338336B (en) 2007-11-20 2016-04-07 Ambrx Inc Modified insulin polypeptides and their uses.
EP2247743B1 (en) 2008-02-08 2016-04-06 Ambrx, Inc. Modified leptin polypeptides and their uses
ES2963062T3 (en) 2008-07-23 2024-03-25 Ambrx Inc Modified bovine G-CSF polypeptides and their uses
EA019653B1 (en) 2008-09-26 2014-05-30 Амбркс Инк. Modified animal erythropoietin polypeptides and their uses
TR201802361T4 (en) 2008-09-26 2018-03-21 Ambrx Inc Microorganisms and vaccines dependent on unnatural amino acid replication.
US20120283172A1 (en) 2009-12-21 2012-11-08 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
CA2784793A1 (en) 2009-12-21 2011-07-21 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
MX346786B (en) 2010-08-17 2017-03-31 Ambrx Inc Modified relaxin polypeptides and their uses.
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
TWI480288B (en) 2010-09-23 2015-04-11 Lilly Co Eli Formulations for bovine granulocyte colony stimulating factor and variants thereof
EP3909596A1 (en) 2014-10-24 2021-11-17 Bristol-Myers Squibb Company Modified fgf-21 polypeptides and uses thereof
MY193457A (en) 2017-02-08 2022-10-14 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW280833B (en) * 1990-12-27 1996-07-11 Hoffmann La Roche
EP0533006A1 (en) * 1991-09-18 1993-03-24 F.Hoffmann-La Roche & Co. Aktiengesellschaft Chimaeric interleukin 5-receptor/immunoglobulin polypeptides

Also Published As

Publication number Publication date
WO1997026332A1 (en) 1997-07-24

Similar Documents

Publication Publication Date Title
AU1690697A (en) Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin antagonists
AU3659897A (en) Chemokine receptor antagonists and methods of use therefor
ZA964744B (en) Crf receptor antagonists and methods relating thereto
IL118476A0 (en) Hepatocyte growth factor receptor antagonists and uses thereof
AU7692996A (en) Receptor antagonists
PL321538A1 (en) Additional protein of a human interleukin-1 receptor
EP0828751A4 (en) Human neuropeptide receptor
AU3953795A (en) Bicyclic neuropeptide y receptor antagonists
AU7576096A (en) Il-13 receptor polypeptide
AU2020497A (en) Receptor and transporter antagonists
AU3311199A (en) Melanocortin receptor antagonists and modulations of melanocortin receptor activity
AU6132998A (en) Constitutively active g protein coupled receptor of hhv 8 and method
AU6524794A (en) Cloned receptors and methods for screening
AU6263996A (en) Method for screening for receptor agonists and antagonists
GB9521696D0 (en) Combination of LTD4 receptor antagonists with glucocorticosteriods
AU5449194A (en) Combinations of angiotensin-ii receptor antagonists and diuretics
AU3681795A (en) Polypeptide agonists and antagonists of human interleukin-8
PL330708A1 (en) Derivatives of indolydine useful as antagonists of 5-ht-2c receptor
AU4768899A (en) Peptide antagonists of the human urokinase receptor and method for selecting them
AU1242800A (en) Isolated vshk-1 receptor polypeptides and methods of use thereof
AU2408397A (en) Ob protein receptor genes and use of the same
AU6685398A (en) Calcium independent receptor of alpha-latrotoxin, characterization and uses thereof
AU3935897A (en) B1-bradykinin receptor antagonists and use thereof
AU4753496A (en) Human g-protein coupled receptor
AU6125096A (en) C5a receptor antagonists having substantially no agonist activity and methods for preparation